[Skip to Content]
[Skip to Content Landing]
Article
September 1939

THIOCYANATE DERMATITIS: REPORT OF A CASE

Author Affiliations
Assistant Resident in Internal Medicine; Research Associate in Dermatology and Syphilology ANN ARBOR, MICH.
Arch Intern Med (Chic). 1939;64(3):579-585. doi:10.1001/archinte.1939.00190030172012
Abstract

The ability of the thiocyanates to lower the blood pressure was observed as early as 1903 by Pauli,1 but the drugs were not introduced in the treatment of hypertension until 1924, by Westphal.2 Their use has been limited, however, because of the toxic effects frequently produced. In 1932 Goldring and Chasis3 reported the toxic symptoms which occurred in 13 of 50 patients treated for hypertension with thiocyanate. These symptoms consisted of muscular fatigue, nausea and vomiting, mental confusion, hallucinations and motor aphasia. They also reported 2 deaths, preceded by delirium, convulsive twitchings and coma. They pointed out that some persons show a distinct susceptibility to the drug.

In 1926 Takacs4 reported the first case of dermatitis due to thiocyanate. This was a papular eruption which occurred after the ingestion of 1 Gm. of potassium thiocyanate daily for nine days. Since that time there have been reported numerous cases of mild

References
1.
Pauli, W.:  Ueber Ionenwirkungen und ihre therapeutische Verwendung ,  München. med. Wchnschr. 50:153-157 ( (Jan. 27) ) 1903.
2.
Westphal, K.:  Untersuchungen zur Frage der Entstehungsbedingungen des genuinen arteriellen Hochdruckes: I. Die paradoxe Gefässreaktion auf Abschnürung bei arterielle Hochdruck ,  Ztschr. f. klin. Med. 101:545-557, 1925.
3.
Goldring, W., and Chasis, H.:  Thiocyanate Therapy in Hypertension: I. Observations on Its Toxic Effects ,  Arch. Int. Med. 49:321-329 ( (Feb.) ) 1932.Crossref
4.
Takacs, L.:  Versuche mit Rhodansalzen: I. Einfluss des Rhodan auf Magensekretion, weisse Blutkörperchen, Pulsschlag und Blutdruck ,  Ztschr. f. d. ges. exper. Med. 50:432-439, 1926.
5.
Gager, L. T.:  The Incidence and Management of Hypertension, with a Note on Sulfocyanate Therapy ,  J. A. M. A. 90:82-86 ( (Jan. 14) ) 1928.Crossref
6.
Borg, J. F.:  Experiences in the Use of the Sulfocyanates ,  Minnesota Med. 13:293-296 ( (May) ) 1930.
7.
Baker, T. W., and Brunsting, L. A.:  Dermatitis Medicamentosa Resulting from the Administration of Sulfocyanates in the Treatment of Hypertension ,  J. A. M. A. 108:549-550 ( (Feb. 13) ) 1937.Crossref
8.
Barker, M. H.: Personal communication to the authors.
9.
Logefeil, R. C.:  Observations on the Use of Potassium Sulfocyanate (Rhodan) in the Treatment of Essential Hypertension ,  Minnesota Med. 12:151-159 ( (March) ) 1929.
10.
Weis, C. R., and Ruedemann, R.:  Exfoliative Dermatitis from Potassium Sulphocyanate Therapy ,  J. A. M. A. 93:988 ( (Sept. 28) ) 1929.Crossref
11.
Ayman, D.:  Exfoliative Dermatitis from Potassium Thiocyanate ,  J. A. M. A. 93:1671 ( (Nov. 23) ) 1929.
12.
Barker, M. H.:  The Blood Cyanates in the Treatment of Hypertension ,  J. A. M. A. 106:762-767 ( (March 7) ) 1936.Crossref
13.
Schreiber, H.:  Ueber den Rhodangehalt in menschlichen Blutserum ,  Biochem. Ztschr. 163:241-251, 1925.
14.
Lashmet, F. H., and Newburgh, L. H.:  An Improved Concentration Test of Renal Function ,  J. A. M. A. 99:1396-1398 ( (Oct. 22) ) 1932.Crossref
×